Drug intelligence / Profile preview

XCEL-MT-OSTEO-BETA

Development stage: Phase 2
Lead developer: Xcelia
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intraosseous, Surgical Implantation, Intralesional

Overview

XCEL-MT-OSTEO-BETA is a tissue-engineered medicinal product (ATMP) consisting of ex vivo expanded allogenic adult mesenchymal stem cells (MSCs) seeded onto an allogenic human bone tissue scaffold. Developed by the Banc de Sang i Teixits (BST) in Spain, it is designed to promote bone regeneration and healing in complex fractures, specifically proximal femur (hip) fractures in elderly patients. The product combines the osteogenic potential of stem cells with the structural support and osteoconductive properties of allograft bone. It has been investigated in pilot clinical trials to evaluate its safety and preliminary efficacy in improving surgical outcomes and bone union compared to standard treatments.

Other names: ex vivo expanded allogenic adult stem cells combined with allogenic human bone tissue

Beyond the preview

Go deeper on XCEL-MT-OSTEO-BETA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XCEL-MT-OSTEO-BETA.

Explore the full profile